Author

C. Talbot Cooper

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:protein structure· 1

Frequent Co-Authors

H. Kusano· 1 shared H. Zeng· 1 shared J. D. Best· 1 shared M. H. Jones· 1 shared N. E. Quispe Calla· 1 shared R. Smith· 1 shared S. Rudge· 1 shared T. Shiomi· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

H. Kusano

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystals

M. H. Jones, N. E. Quispe Calla, R. Smith, C. Talbot Cooper, S. Rudge, H. Kusano, T. Shiomi, Y. Ishikawa, H. Zeng, J. D. Best

This study demonstrates that PODS-IL-2, a phagocytic-competent protein co-crystal, can deliver low-dose IL-2 effectively for treating melanoma and renal cell carcinoma with improved tolerability.

bioRxiv · Apr 6, 2023 · PreprintCancer Biology